IMMUNOREGULATORY ABNORMALITIES IN MUCOCUTANEOUS LYMPH-NODE SYNDROME
IMMUNOREGULATORY ABNORMALITIES IN MUCOCUTANEOUS LYMPH-NODE SYNDROME
复制标题
DOI:
10.1016/0090-1229(82)90075-7
复制
发表时间:
1982-01-01
期刊:
影响因子:
--
通讯作者:
GEHA, RS
中科院分区:
文献类型:
--
作者:
LEUNG, DYM;SIEGEL, RL;GEHA, RS
The immune status of 21 children in the acute phase of mucocutaneous lymph node syndrome (MCLS) was assessed and compared to that of control populations, consisting of age-matched normal children and of children suffering from acute febrile nonbacterial illnesses. In contrast to the controls, 13 of 18 patients studied during the acute phase of MCLS had a significant reduction in circulating [monoclonal antibody] T8-positive (T8+) suppressor/cytotoxic T cells (P < 0.001), but normal percentages of [monoclonal antibody] T3-positive (T3+) total T cells and of [monoclonal antibody] T4-positive (T4+) helper T cells (P > 0.05). Three of 3 patients had a significantly increased number of Ia-bearing T cells, suggesting the presence of circulating activated helper cells. Seventeen of 18 patients with acute MCLS had a significantly elevated number of circulating cells spontaneously secreting IgG (P < 0.01) and IgM (P < 0.001) as determined by a reverse hemolytic plaque assay. Mononuclear cells from 18 of 20 patients with acute MCLS had increased cytotoxicity against 51Cr-labeled normal human skin fibroblasts (P < 0.01). Follow-up studies during the convalescence phase of MCLS indicated that most of the patients had gradual resolution of their immunologic abnormalities. Immunoregulatory abnormalities may contribute to the pathogenesis of this syndrome.